A

Alpha IVF Group Bhd
KLSE:ALPHA

Watchlist Manager
Alpha IVF Group Bhd
KLSE:ALPHA
Watchlist
Price: 0.245 MYR Market Closed
Market Cap: 1.2B MYR

Wall St Price Targets

ALPHA Price Targets Summary
Alpha IVF Group Bhd

Wall Street analysts forecast ALPHA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ALPHA is 0.357 MYR with a low forecast of 0.333 MYR and a high forecast of 0.389 MYR.

Lowest Forecast
Price Target
0.333 MYR
36% Upside
Average Forecast
Price Target
0.357 MYR
46% Upside
Highest Forecast
Price Target
0.389 MYR
59% Upside
Alpha IVF Group Bhd Competitors:
Price Targets
CNC
Concurrent Technologies PLC
13% Upside

Revenue
Forecast

13% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
13% / Year
Past Growth
19% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 19%.

Gross Profit
Forecast

18% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
18% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 14%.

Operating Income
Forecast

6% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
24% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 24%.

Pre-Tax Income
Forecast

6% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
6% / Year
Past Growth
21% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 21%.

Net Income
Forecast

4% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
4% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 2 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ALPHA's stock price target?
Price Target
0.357 MYR

According to Wall Street analysts, the average 1-year price target for ALPHA is 0.357 MYR with a low forecast of 0.333 MYR and a high forecast of 0.389 MYR.

What is the Revenue forecast for Alpha IVF Group Bhd?
Projected CAGR
19%

Over the last 2 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 19%.

What is the Gross Profit forecast for Alpha IVF Group Bhd?
Projected CAGR
14%

Over the last 2 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 14%.

What is the Operating Income forecast for Alpha IVF Group Bhd?
Projected CAGR
24%

Over the last 2 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 3 years is 24%.

What is the Pre-Tax Income forecast for Alpha IVF Group Bhd?
Projected CAGR
21%

Over the last 2 years, the compound annual growth rate for Pre-Tax Income has been 6%. The projected CAGR for the next 3 years is 21%.

What is the Net Income forecast for Alpha IVF Group Bhd?
Projected CAGR
20%

Over the last 2 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett